From Phosphaturia to Cardiovascular Protection: Is FGF-23 the Heart of the Matter?

Por Toto, Robert D.
Publicado no Circulation (2015)

Transplantation: The role of RAAS blockade in kidney transplantation

Por Toto, Robert D.
Publicado no Nat Rev Nephrol (2015)

Serum Potassium and Cardiovascular Outcomes: The Highs and the Lows

Por Toto, Robert D.
Publicado no Clin J Am Soc Nephrol (2017)

Aldosterone Blockade in chronic Kidney Disease: Can it Improve Outcome?

Por Toto, Robert D.
Publicado no Curr Opin Nephrol Hypertens (2010)

Bardoxolone—the Phoenix?

Por Toto, Robert D.
Publicado no J Am Soc Nephrol (2018)

Defining Hypertension: Role of New Trials and Guidelines

Por Toto, Robert D.
Publicado no Clin J Am Soc Nephrol (2018)

Anemia, Diabetes, and Chronic Kidney Disease

Por Mehdi, Uzma, Toto, Robert D.
Publicado em 2009

Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients?

Por Inrig, Jula K., Toto, Robert D
Publicado no Am J Kidney Dis (2009)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy

Por Srivastava, Anand, Adams-Huet, Beverley, Vega, Gloria L, Toto, Robert D
Publicado no J Investig Med (2016)

Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wa...

Por Inrig, Jula K., Patel, Uptal D., Toto, Robert D., Szczech, Lynda A.
Publicado em 2009

Prevalence of Major Depressive Episode in CKD

Por Hedayati, S. Susan, Minhajuddin, Abu T., Toto, Robert D., Morris, David W., Rush, A. John
Publicado em 2009

Validation of Depression Screening Scales in Patients With CKD

Por Hedayati, S. Susan, Minhajuddin, Abu T., Toto, Robert D., Morris, David W., Rush, A. John
Publicado em 2009

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Por Mehdi, Uzma F., Adams-Huet, Beverley, Raskin, Philip, Vega, Gloria L., Toto, Robert D.
Publicado em 2009

Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy

Por Van Buren, Peter N., Adams-Huet, Beverley, Nguyen, Mark, Molina, Christopher, Toto, Robert D.
Publicado em 2014

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT

Por Chertow, Glenn M., Beddhu, Srinivasan, Lewis, Julia B., Toto, Robert D., Cheung, Alfred K.
Publicado no J Am Soc Nephrol (2016)

Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients

Por Desai, Nihar R., Rowan, Christopher G., Alvarez, Paula J., Fogli, Jeanene, Toto, Robert D.
Publicado no J Drug Assess (2019)

Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization

Por Desai, Nihar R., Rowan, Christopher G., Alvarez, Paula J., Fogli, Jeanene, Toto, Robert D.
Publicado no PLoS One (2020)

Association Between Major Depressive Episodes in Patients With Chronic Kidney Disease and Initiation of Dialysis, Hospitalization, or Death

Por Susan Hedayati, S., Minhajuddin, Abu T., Afshar, Masoud, Toto, Robert D., Trivedi, Madhukar H., John Rush, A.
Publicado em 2010

Intradialytic Hypertension and its Association with Endothelial Cell Dysfunction

Por Inrig, Jula K., Van Buren, Peter, Kim, Catherine, Vongpatanasin, Wanpen, Povsic, Thomas J., Toto, Robert D.
Publicado em 2011

Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients with vs. without Chronic Kidney Disease

Por Jain, Nishank, Li, Xilong, Adams-Huet, Beverley, Sarode, Ravi, Toto, Robert D., Banerjee, Subhash, Hedayati, S. Susan
Publicado no Am J Cardiol (2015)